185 related articles for article (PubMed ID: 31889177)
1. Development of a subcutaneous ear implant to deliver an anaplasmosis vaccine to dairy steers.
Curtis AK; Reif KE; Kleinhenz MD; Martin MS; Skinner B; Kelly SM; Jones DE; Schaut RG; Reppert EJ; Montgomery SR; Narasimhan B; Anantatat T; Jaberi-Douraki M; Coetzee JF
J Anim Sci; 2020 Jun; 98(6):. PubMed ID: 31889177
[TBL] [Abstract][Full Text] [Related]
2. Vaccination of cattle with Anaplasma marginale derived from tick cell culture and bovine erythrocytes followed by challenge-exposure with infected ticks.
de la Fuente J; Kocan KM; Garcia-Garcia JC; Blouin EF; Claypool PL; Saliki JT
Vet Microbiol; 2002 Oct; 89(2-3):239-251. PubMed ID: 12243900
[TBL] [Abstract][Full Text] [Related]
3. Comparison of three methods of immunization against bovine anaplasmosis: an examination of postvaccinal effects.
Corrier DE; Vizcaino O; Carson CA; Ristic M; Kuttler KL; Treviño GS; Lee AJ
Am J Vet Res; 1980 Jul; 41(7):1062-5. PubMed ID: 7436099
[TBL] [Abstract][Full Text] [Related]
4. Cross-protection between geographically distinct Anaplasma marginale isolates appears to be constrained by limited antibody responses.
Kenneil R; Shkap V; Leibovich B; Zweygarth E; Pfister K; Ribeiro MF; Passos LM
Transbound Emerg Dis; 2013 Nov; 60 Suppl 2():97-104. PubMed ID: 24589108
[TBL] [Abstract][Full Text] [Related]
5. Frozen and fresh Anaplasma centrale vaccines in the protection of cattle against Anaplasma marginale infection.
Abdala AA; Pipano E; Aguirre DH; Gaido AB; Zurbriggen MA; Mangold AJ; Guglielmone AA
Rev Elev Med Vet Pays Trop; 1990; 43(2):155-8. PubMed ID: 2092348
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the effectiveness of an inactivated vaccine from Anaplasma marginale derived from tick cell culture.
Lasmar PV; Carvalho AÚ; Facury Filho EJ; Bastos CV; Ribeiro MF
Rev Bras Parasitol Vet; 2012; 21(2):112-7. PubMed ID: 22832750
[TBL] [Abstract][Full Text] [Related]
7. Immunization of bovines using a DNA vaccine (pcDNA3.1/MSP1b) prepared from the Jaboticabal strain of Anaplasma marginale.
de Andrade GM; Machado RZ; Vidotto MC; Vidotto O
Ann N Y Acad Sci; 2004 Oct; 1026():257-66. PubMed ID: 15604503
[TBL] [Abstract][Full Text] [Related]
8. Immunization of cattle with Anaplasma marginale derived from tick cell culture.
Kocan KM; Halbur T; Blouin EF; Onet V; de la Fuente J; Garcia-Garcia JC; Saliki JT
Vet Parasitol; 2001 Dec; 102(1-2):151-61. PubMed ID: 11705661
[TBL] [Abstract][Full Text] [Related]
9. Study of an attenuated Anaplasma marginale vaccine in Mexico natural challenge of immunity in an enzootic area.
Osorno MB; Solana PM; Perez JM; Lopez TR
Am J Vet Res; 1975 May; 36(5):631-3. PubMed ID: 1137209
[TBL] [Abstract][Full Text] [Related]
10. Antigens and alternatives for control of Anaplasma marginale infection in cattle.
Kocan KM; de la Fuente J; Guglielmone AA; Meléndez RD
Clin Microbiol Rev; 2003 Oct; 16(4):698-712. PubMed ID: 14557295
[TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of a double-antigen sandwich ELISA to identify
Sarli M; Thompson CS; Novoa MB; Valentini BS; Mastropaolo M; Echaide IE; de Echaide ST; Primo ME
J Vet Diagn Invest; 2020 Jan; 32(1):70-76. PubMed ID: 31777316
[TBL] [Abstract][Full Text] [Related]
12. Comparison of three methods of immunization against bovine anaplasmosis: evaluation of protection afforded against field challenge exposure.
Vizcaino O; Corrier DE; Terry MK; Carson CA; Lee AJ; Kuttler KL; Ristic M; Treviño GS
Am J Vet Res; 1980 Jul; 41(7):1066-8. PubMed ID: 7436100
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of purified Anaplasma marginale initial bodies as a vaccine against anaplasmosis.
Montenegro-James S; James MA; Benitez MT; Leon E; Baek BK; Guillen AT
Parasitol Res; 1991; 77(2):93-101. PubMed ID: 2027888
[TBL] [Abstract][Full Text] [Related]
14. Protective immunity induced by immunization with a live, cultured Anaplasma marginale strain.
Hammac GK; Ku PS; Galletti MF; Noh SM; Scoles GA; Palmer GH; Brayton KA
Vaccine; 2013 Aug; 31(35):3617-22. PubMed ID: 23664994
[TBL] [Abstract][Full Text] [Related]
15. Immune response and biochemistry of calves immunized with rMSP1a ( Anaplasma marginale) using carbon nanotubes as carrier molecules.
Silvestre BT; Silveira JAGD; Facury-Filho EJ; Carvalho AÚ; Versiani AF; Estevam LGTM; Araújo MSS; Martins-Filho OA; Negrão-Corrêa DA; Ribeiro MFB
Rev Bras Parasitol Vet; 2018; 27(2):191-202. PubMed ID: 29846449
[TBL] [Abstract][Full Text] [Related]
16. Anaplasma marginale inactivated vaccine: dose titration against a homologous challenge.
Rodríguez SD; Garcîa Ortiz MA; Hernández Salgado G; Santos Cerda NA; Aboytes Torre R; Cantó Alarcón GJ
Comp Immunol Microbiol Infect Dis; 2000 Oct; 23(4):239-52. PubMed ID: 11038126
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with perceived Anaplasma marginale infection and clinical anaplasmosis cases on beef operations in California.
Chen SY; Forero L; Davy J; Stackhouse J; Harvey D; Abdelfattah E; Maier G
Ticks Tick Borne Dis; 2024 Jul; 15(4):102346. PubMed ID: 38643720
[TBL] [Abstract][Full Text] [Related]
18. A partially purified outer membrane protein VirB9-1 for low-cost nanovaccines against Anaplasma marginale.
Zhao L; Cavallaro AS; Wibowo D; Zhang B; Zhang J; Mitter N; Yu C; Zhao CX; Middelberg AP
Vaccine; 2017 Jan; 35(1):77-83. PubMed ID: 27890399
[TBL] [Abstract][Full Text] [Related]
19. Mapping of B-cell epitopes in the N-terminal repeated peptides of Anaplasma marginale major surface protein 1a and characterization of the humoral immune response of cattle immunized with recombinant and whole organism antigens.
Garcia-Garcia JC; de la Fuente J; Kocan KM; Blouin EF; Halbur T; Onet VC; Saliki JT
Vet Immunol Immunopathol; 2004 Apr; 98(3-4):137-51. PubMed ID: 15010223
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of attenuated Anaplasma marginale vaccine under laboratory and field conditions in Colombia.
Vizcaino O; Carson CA; Lee AJ; Ristic M
Am J Vet Res; 1978 Feb; 39(2):229-33. PubMed ID: 629456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
